-The Times of India NEW DELHI: The government announced on Friday that 'Janaushadhi' stores will be opened in every block to make low-priced generic medicines available across the country. The scheme is expected to create a "silent revolution" in achieving health security by providing affordable and quality medicines for all. Union minister for chemicals & fertilizers Ananth Kumar said the government plans to open such stores so that doctors and pharmacists cannot push...

-The Hindu The core issues are affordable access to medicines and their rational prescription and use The Medical Council of India (MCI) issued a circular on April 21 drawing attention to clause 1.5 of its regulations regarding the professional conduct of doctors: “Every physician should prescribe drugs with generic names legibly and preferably in capital letters and he/she shall ensure that there is a rational prescription of drugs.” Further, the circular said,...

-The Times of India NEW DELHI: The Indian Medical Association (IMA) has asked its state and local units to raise funds from member doctors to organise conferences and functions instead of seeking sponsorship. According to IMA office-bearers, the decision was taken at a meeting on Wednesday in view of allegations about pharmaceutical companies and the device industry shaping the content and style of medical conferences. "If doctors want to meet at a...

-The Times of India NEW DELHI: doctors and public health groups have come together to suggest that the government should phase out branded drugs in a calibrated manner and ban differential pricing under different brands to promote generic drug prescriptions. This comes in the wake of PM Narendra Modi's announcement that the government was working on a legal framework to ensure that doctors mandatorily prescribed low cost generic medicines. Following the PM's...

-The Telegraph New Delhi: The government's price cap on coronary stents has not deterred the health-care industry from continuing to offer hospitals profit opportunities of tens of thousands of rupees on other kinds of stents, concerned doctors and health-care industry representatives said.     The National Pharmaceutical Pricing Authority (NPPA), the government's price regulator, had on February 15 imposed a cap of about Rs 30,000 on coronary stents. But hospitals can continue to...